Schedule I (Convention on Psychotropic Substances)
GPTKB entity
Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug_schedule
|
| gptkbp:adoptedBy |
gptkb:United_Nations
1971 |
| gptkbp:appliesTo |
all signatory countries
|
| gptkbp:contains |
gptkb:MDMA
gptkb:LSD gptkb:THC psilocybin mescaline cathinone |
| gptkbp:criteria |
substances with high abuse potential and no recognized medical use
|
| gptkbp:enforcedBy |
gptkb:International_Narcotics_Control_Board
|
| gptkbp:partOf |
gptkb:Convention_on_Psychotropic_Substances
|
| gptkbp:purpose |
restrict manufacture, distribution, and use of listed substances
|
| gptkbp:regulates |
gptkb:psychotropic_substances
|
| gptkbp:bfsParent |
gptkb:lysergic_acid_diethylamide
|
| gptkbp:bfsLayer |
8
|
| http://www.w3.org/2000/01/rdf-schema#label |
Schedule I (Convention on Psychotropic Substances)
|